All terms in GO
| Label | Id | Description |
|---|---|---|
| negative regulation of synaptic vesicle lumen acidification | GO_1901547 |
Any process that stops, prevents or reduces the frequency, rate or extent of synaptic vesicle lumen acidification.
|
| positive regulation of synaptic vesicle lumen acidification | GO_1901548 |
Any process that activates or increases the frequency, rate or extent of synaptic vesicle lumen acidification.
|
| GO_1901549 | GO_1901549 | |
| regulation of endothelial cell development | GO_1901550 |
Any process that modulates the frequency, rate or extent of endothelial cell development.
|
| regulation of endothelial cell differentiation | GO_0045601 |
Any process that modulates the frequency, rate or extent of endothelial cell differentiation.
|
| negative regulation of endothelial cell development | GO_1901551 |
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell development.
|
| negative regulation of endothelial cell differentiation | GO_0045602 |
Any process that stops, prevents, or reduces the frequency, rate or extent of endothelial cell differentiation.
|
| positive regulation of endothelial cell development | GO_1901552 |
Any process that activates or increases the frequency, rate or extent of endothelial cell development.
|
| malonic acid transport | GO_1900752 |
The directed movement of a malonic acid into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
| response to paracetamol | GO_1901554 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a paracetamol stimulus.
|
| obsolete response to paclitaxel | GO_1901555 |
OBSOLETE. Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a paclitaxel stimulus.
|
| response to candesartan | GO_1901556 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a candesartan stimulus.
|
| response to fenofibrate | GO_1901557 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fenofibrate stimulus.
|
| response to metformin | GO_1901558 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metformin stimulus.
|
| response to ribavirin | GO_1901559 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ribavirin stimulus.
|
| response to purvalanol A | GO_1901560 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a purvalanol A stimulus.
|
| response to purine-containing compound | GO_0014074 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a purine-containing compound stimulus.
|
| aspyridone B catabolic process | GO_1901520 |
The chemical reactions and pathways resulting in the breakdown of aspyridone B.
|
| aspyridone B biosynthetic process | GO_1901521 |
The chemical reactions and pathways resulting in the formation of aspyridone B.
|
| icosanoid catabolic process | GO_1901523 |
The chemical reactions and pathways resulting in the breakdown of icosanoid.
|